i should be asking and not saying - maybe it should have

New Post Public Reply Private Reply Replies (0) Message Board
seemingly-harmless ohm20 #156998
562
i should be asking and not saying - maybe it should have been in the form of a question, because i dont know.

so...no, to not turn things around, but save the IP even if it was for themselves, (and not hand it over on a platter to BP) and in the end get the drug on the market... but it did seem like the ship was sinking at the time. is it safe to say that cytodyn came dangerously close to liquidation? i think its safe to say that patterson and later 13D/pestell said - "hey wait a minute" and werent going to let such an important and valuable asset vanish and they did what any rational professionals would be expected to do. and im pretty sure that the group was not about to sit on their hands and wait for nader to do something brilliant.

just curious as to what other smart people would have done in their shoes. i do not have that level of intelligence. but in that situation, usually the stockholders are not the first concern, the IP is.

but we are not sinking anymore, we are within an inch of truly open water, and im getting excited again like when i saw pattersons' tedx talk for the first time and covid patients were "magically" getting of off ventilators . now 5 therapy resistant cancer patients given leronlimab are "magically" alive after 3 years, 4 of which have no signs of disease, the 5th stabilized with no progression. technically and previously impossible. it still amazes me that the data being released over this entire time hasnt triggered at least one generous buyout offer. havent other companies been acquired on far less data? still, i dont want cytodyn to be acquired - ever - , that would be capitulation. most of us are here because this "too good to be true" story is actually true. the science so far has said so. science wins. at least it should. science + solid leadership wins. im counting on it.

Quote:
Quote: i said - what good would the patent be if the company is bankrupt and the next phantom party would have to acquire it somehow at some cost in a bankruptcy liquidation hearing


Quote:
So you're saying that Patterson trying to force Cytodyn to buy his company at an extremely inflated price to take control of his "patent" was meant to turn things around? Back then I dug through the financial numbers for IncellDX and they were making next to nothing and I posted about it.




CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Russel Metals Shows Strong Performance in Latest Earnings Report

Updated Category News Views 240

Russel Metals Inc. Reports Third Quarter Results for 2025 Russel Metals Inc. (TSX:RUS) has recently shared its financial performance for the three-month period ending September 30, 2025. The results reflect a positive trajectory in revenue and strategic initiatives to enhance its market position. Key Financial Metrics Overview In this quarter, Russel Metals has...

Continue Reading
KBC Group Shows Strong Capital Resilience Ahead of Changes

Updated Category News Views 257

KBC Group's Capital Position Remains Strong KBC Group has reported a robust standing in its capital levels, significantly exceeding the minimum capital requirements mandated by the European Central Bank (ECB). As part of the Supervisory Review and Evaluation Process (SREP) scheduled for the upcoming year, KBC received formal notification regarding its capital metrics....

Continue Reading
Synlogic's Q3 Financial Update Highlights Strategic Review

Updated Category News Views 79

Synlogic Provides Third Quarter 2024 Financial Results Synlogic, Inc. (NASDAQ: SYBX), a prominent biopharmaceutical firm dedicated to developing innovative therapeutics for serious diseases, has recently outlined its financial performance for the third quarter of 2024. The organization is actively working on advancing its mission to enhance healthcare through...

Continue Reading
Incannex Healthcare Sees Growth with Positive Fiscal Results

Updated Category News Views 98

Incannex Healthcare's Remarkable Financial Progress Incannex Healthcare Inc. (NASDAQ: IXHL) is making impressive strides in the biopharmaceutical world, focusing on breakthrough treatments for chronic diseases. Their recent fiscal year report outlines not only financial outcomes but also a plethora of operational and clinical advancements aimed at addressing significant...

Continue Reading
Revolutionizing Finance with ChatAnalyst at Alpha Liquid Terminal

Updated Category News Views 167

Alpha Liquid Terminal Introduces ChatAnalyst Financial Agent Recently, a game-changing tool was launched that promises to redefine how individuals manage and interpret financial data. This is powered by the innovative company, Alpha Liquid Terminal. The newly unveiled AI-driven financial analyst agent, known as ChatAnalyst, is designed to simplify and streamline financial...

Continue Reading